Works matching IS 00070963 AND DT 2025 AND VI 192

Results: 256
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Environmental triggers of psoriasis: insights from a UK patient-reported cohort (mySkin) Open Access.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 1138, doi. 10.1093/bjd/ljaf073
    By:
    • Kroah-Hartman, Madeline;
    • Lee, John Y W;
    • Dooley, Niamh;
    • Tan, Wei Ren;
    • Mineur, Maaike F M;
    • Paolino, Alexandra;
    • Pizzato, Jade;
    • Jackson-Duffy, Freya;
    • Powell, Kingsley;
    • Sagoo, Manpreet K;
    • Sewell, Georgia;
    • Lancelot, Camille;
    • Moorhead, Lucy;
    • McAteer, Helen;
    • Coker, Bolaji;
    • Weinman, John;
    • Barker, Jonathan N;
    • Chapman, Sarah;
    • Norton, Sam;
    • Smith, Catherine H
    Publication type:
    Article
    14
    15
    16
    17
    18
    19

    Improvement in dermatomyositis-associated muscle disease with anifrolumab.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 1126, doi. 10.1093/bjd/ljaf064
    By:
    • Shayegan, Leila H;
    • Shaw, Katharina S;
    • Wieschhoff, Ged G;
    • Ezeh, Nnenna;
    • Kim, Yoo Jung;
    • Shahriari, Neda;
    • Anshelevich, Ellen E;
    • Acevedo, Lorena A;
    • LaChance, Avery;
    • Dedeoglu, Fatma;
    • Castillo, Rochelle L;
    • Ho, Allen W;
    • Vleugels, Ruth Ann
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    Generalized granulomatous slack skin.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 1148, doi. 10.1093/bjd/ljae508
    By:
    • Chen, Zirui;
    • Wang, Yang;
    • Wang, Ruojun
    Publication type:
    Article
    39

    Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS) Open Access.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 995, doi. 10.1093/bjd/ljae507
    By:
    • Silverberg, Jonathan I;
    • Eichenfield, Lawrence F;
    • Blauvelt, Andrew;
    • Irvine, Alan D;
    • Guttman-Yassky, Emma;
    • Langley, Richard G;
    • Warren, Richard B;
    • French, Lars E;
    • Felding, Jakob;
    • Weiss, Anne;
    • Pedersen, Claus B;
    • Jensen, Morten L;
    • Carlsson, Anna;
    • Sommer, Morten O A;
    • Kjøller, Kim;
    • Simpson, Eric L
    Publication type:
    Article
    40
    41
    42

    Haematohidrosis.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 1151, doi. 10.1093/bjd/ljae499
    By:
    • Pathania, Yashdeep Singh
    Publication type:
    Article
    43
    44

    The efficacy and safety of first-line metastatic melanoma treatment with ipilimumab + nivolumab vs. nivolumab in a real-world setting.

    Published in:
    British Journal of Dermatology, 2025, v. 192, n. 6, p. 1096, doi. 10.1093/bjd/ljae470
    By:
    • Billard, Karine;
    • Mortier, Laurent;
    • Dereure, Olivier;
    • Dalac, Sophie;
    • Montaudié, Henri;
    • Legoupil, Delphine;
    • Dutriaux, Caroline;
    • Quatrebarbes, Julie De;
    • Maubec, Eve;
    • Leccia, Marie-Thérèse;
    • Granel-Brocard, Florence;
    • Brunet-Possenti, Florence;
    • Arnault, Jean-Philippe;
    • Gaudy-Marqueste, Caroline;
    • Pages, Cecile;
    • Saiag, Philippe;
    • L'Orphelin, Jean-Matthieu;
    • Zehou, Ouidad;
    • Lesimple, Thierry;
    • Allayous, Clara
    Publication type:
    Article
    45
    46
    47
    48
    49
    50